The two companies will work together to manage the transition, and aim to close the sale by the end of first quarter of calendar year 2019. This acquisition is an important addition to the company’s network of 24 diagnostic labs across India, especially as they continue to expand their work in oncology, genomics, and precision medicine.
HCG is the largest provider of cancer care in India. Through its network of comprehensive cancer centres spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.
